Dermata Therapeutics Inc (DRMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 1,992 |
| Other current assets | 73 |
| TOTAL | $2,065 |
| Non-Current Assets | |
| TOTAL | $N/A |
| Total Assets | $2,066 |
| Liabilities | |
| Current Liabilities | |
| Short Term Debt | 731 |
| Accounts payable and accrued liabilities | 337 |
| Accrued Expenses | 155 |
| Other current liabilities | 500 |
| TOTAL | $1,723 |
| Non-Current Liabilities | |
| Long Term Debt | 553 |
| TOTAL | $553 |
| Total Liabilities | $2,276 |
| Shareholders' Equity | |
| Common Shares | 2,353 |
| Retained earnings | -24,843 |
| Other shareholders' equity | 22,280 |
| TOTAL | $-210 |
| Total Liabilities And Equity | $2,066 |